~~<i id='3B7DABF473'><strike id='3B7DABF473'><tt id='3B7DABF473'><pre id='3B7DABF473'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

focus

author：explore 2025-10-02 18:49:41 - browse：377

In a dark grey suit and light blue button-down shirt, Bill Sibold, CEO of Madrigal Pharmaceuticals, smiles— coverage from STAT — Madrigal CEO Bill Sibold says the company is "interested in the patients who are most in need." Madrigal Pharmaceuticals

The Food and Drug Administration is expected to approve the first medicine developed specifically to treat the serious liver disease known as MASH as soon as this week.

The pill, called resmetirom, is made by Madrigal Pharmaceuticals.

Metabolic dysfunction-associated steatohepatitis, or MASH and previously called NASH, is often associated with obesity. The accumulation of fat in the liver causes inflammation, which leads to fibrosis, or liver scarring, and can progress in more advanced stages to cirrhosis, cancer, and the need for a liver transplant.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Readout LOUD podcast: The Sarepta saga, decoding biotech hype

explore

focus

Wikipedia

focus

Wikipedia

KristineChuaIllustration:STAT;Courtesy:KristineChuaChimeras—fantasticalcreaturescomposedofdifferenta

WSS

Gene therapy’s promise and the high cost of hope

Make 'food is medicine' a key part of White House nutrition meeting

Listen: PBM conflicts, RSV vaccines, & the future of flu season

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

Medicare proceeds with plan to claw back hospital funds

Grail is spending more than ever lobbying Congress

Wikipedia

focus

explore

23andMe had bad news about my health. I wish a person had delivered it

Sarepta Duchenne therapy fails to meet primary endpoint in trial

How to save PrEP access — and even expand it

Coloradans with cystic fibrosis could lose access to Trikafta

The cancer drug shortage isn’t new — and neither are the solutions

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

Anesthesiologist group: stop taking Ozempic before surgery

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

Sports medicine is finally prioritizing gender equality

Infant mortality in U.S. rose last year for first time in decades: CDC

focus

Bill would allow buprenorphine prescription for addiction via telehealth

All of Us, NIH's precision medicine initiative, gets a big boost

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

Key Senate panel to consider PBM, drug pricing reform package

Doctor appointment wait times are getting worse

Inari Medical to buy amputation prevention company LimFlow

focus

Wikipedia

focus

Wikipedia